Zdrowie i gospodarka · 22/06/2010
FDA Releases Guidance for Industry on Developing Medical Products for Systemic Lupus Erythematosus Treatment
The Food and Drug Administration (FDA) has made available a guidance document outlining recommendations for pharmaceutical companies to develop treatments for systemic lupus erythematosus (SLE), a chronic autoimmune disease, and has finalized two related guidance documents on lupus nephritis treatment.